Download
s10434-021-10508-x.pdf 367,85KB
WeightNameValue
1000 Titel
  • Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study
1000 Autor/in
  1. Kurreck, Annika |
  2. Gronau, Felix |
  3. Alberto Vilchez, Miguel Enrique |
  4. Abels, Wiltrud |
  5. Enghard, Philipp |
  6. Brandl, Andreas |
  7. Francis, Roland |
  8. Föhre, Bettina |
  9. Lojewski, Christian |
  10. Pratschke, Johann |
  11. Thuss-Patience, Peter |
  12. Modest, Dominik |
  13. Rau, Beate |
  14. Feldbrügge, Linda |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-08-04
1000 Erschienen in
1000 Quellenangabe
  • 29(1):152-162
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1245/s10434-021-10508-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677645/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Cytoreductive surgery (CRS) in combination with hyperthermic intraperitoneal chemotherapy (HIPEC) represents a multimodal treatment concept for patients with peritoneal surface malignancies. The use of intraperitoneal cisplatin (CDDP) is associated with a risk of acute kidney injury (AKI). The aim of this study is to evaluate the protective effect of perioperative sodium thiosulfate (STS) administration on kidney function in patients undergoing CRS and CDDP-based HIPEC.!##!Patients and methods!#!We retrospectively analyzed clinical data of all patients who underwent CRS and CDDP-based HIPEC at our hospital between March 2017 and August 2020. Patients were stratified according to the use of sodium thiosulfate (STS vs. no STS). We compared kidney function and clinical outcome parameters between both groups and determined risk factors for postoperative AKI on univariate and multivariate analysis. AKI was classified according to acute kidney injury network (AKIN) criteria.!##!Results!#!Of 238 patients who underwent CRS and CDDP-based HIPEC, 46 patients received STS and 192 patients did not. There were no significant differences in baseline characteristics. In patients who received STS, a lower incidence (6.5% vs. 30.7%; p = 0.001) and severity of AKI (p = 0.009) were observed. On multivariate analysis, the use of STS (OR 0.089, p = 0.001) remained an independent kidney-protective factor, while arterial hypertension (OR 5.283, p < 0.001) and elevated preoperative urea serum level (OR 5.278, p = 0.032) were predictors for postoperative AKI.!##!Conclusions!#!The present data suggest that STS protects patients from AKI caused by CRS and CDDP-based HIPEC. Further prospective studies are needed to validate the benefit of STS among kidney-protective strategies.
1000 Sacherschließung
lokal Surgical Oncology
lokal Humans [MeSH]
lokal Acute Kidney Injury/etiology [MeSH]
lokal Cytoreduction Surgical Procedures/adverse effects [MeSH]
lokal Retrospective Studies [MeSH]
lokal Hyperthermic Intraperitoneal Chemotherapy [MeSH]
lokal Surgery
lokal Peritoneal Surface Malignancy
lokal Oncology
lokal Cisplatin/adverse effects [MeSH]
lokal Acute Kidney Injury/prevention
lokal Thiosulfates [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/S3VycmVjaywgQW5uaWth|https://frl.publisso.de/adhoc/uri/R3JvbmF1LCBGZWxpeA==|https://frl.publisso.de/adhoc/uri/QWxiZXJ0byBWaWxjaGV6LCBNaWd1ZWwgRW5yaXF1ZQ==|https://frl.publisso.de/adhoc/uri/QWJlbHMsIFdpbHRydWQ=|https://frl.publisso.de/adhoc/uri/RW5naGFyZCwgUGhpbGlwcA==|https://frl.publisso.de/adhoc/uri/QnJhbmRsLCBBbmRyZWFz|https://frl.publisso.de/adhoc/uri/RnJhbmNpcywgUm9sYW5k|https://frl.publisso.de/adhoc/uri/RsO2aHJlLCBCZXR0aW5h|https://frl.publisso.de/adhoc/uri/TG9qZXdza2ksIENocmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/UHJhdHNjaGtlLCBKb2hhbm4=|https://frl.publisso.de/adhoc/uri/VGh1c3MtUGF0aWVuY2UsIFBldGVy|https://frl.publisso.de/adhoc/uri/TW9kZXN0LCBEb21pbmlr|https://frl.publisso.de/adhoc/uri/UmF1LCBCZWF0ZQ==|https://frl.publisso.de/adhoc/uri/RmVsZGJyw7xnZ2UsIExpbmRh
1000 Hinweis
  • DeepGreen-ID: d26deb0e69ad488986a3d86aec1b735a ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6442680.rdf
1000 Erstellt am 2023-04-26T15:19:21.370+0200
1000 Erstellt von 322
1000 beschreibt frl:6442680
1000 Zuletzt bearbeitet 2023-10-19T13:06:06.872+0200
1000 Objekt bearb. Thu Oct 19 13:06:06 CEST 2023
1000 Vgl. frl:6442680
1000 Oai Id
  1. oai:frl.publisso.de:frl:6442680 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source